Anti‐SARS‐CoV‐2 vaccines in recipient and/or donor before allotransplant

The impact of pre‐transplant anti‐severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) vaccine in 20 recipients of allogeneic hematopoietic stem cell transplantation (Allo‐HSCT) and/or their donors is reported here, showing that the persistence of anti‐SARS‐CoV‐2 antibodies can be detected i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jullien, Maxime, Coste‐Burel, Marianne, Clemenceau, Beatrice, Letailleur, Valentin, Guillaume, Thierry, Peterlin, Pierre, Garnier, Alice, Bourgeois, Amandine Le, Imbert, Berthe‐Marie, Ollier, Jocelyn, Grain, Audrey, Touzeau, Cyrille, Moreau, Philippe, Béné, Marie C, Vié, Henri, Chevallier, Patrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924852/
https://www.ncbi.nlm.nih.gov/pubmed/35313664
http://dx.doi.org/10.1002/jha2.398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924852/
https://www.ncbi.nlm.nih.gov/pubmed/35313664
http://dx.doi.org/10.1002/jha2.398

Ejemplares similares